Cargando…

Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH

BACKGROUND: Hematoma clearance has been a proposed therapeutic strategy for hemorrhagic stroke. This study investigated the impact of CX3CR1 (CX3C chemokine receptor 1) activation mediated by r-FKN (recombinant fractalkine) on hematoma resolution, neuroinflammation, and the underlying mechanisms inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xionghui, He, Xuying, Xu, Feng, Xu, Ningbo, Sharifi, Nona Hashem, Zhang, Pengjie, Flores, Jerry J., Wu, Lei, He, Qiuguang, Kanamaru, Hideki, Zhu, Shiyi, Dong, Siyuan, Han, Mingyang, Yuan, Ye, Huang, Lei, Miao, Liyan, Zhang, John H., Zhou, Youxin, Tang, Jiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453335/ https://www.ncbi.nlm.nih.gov/pubmed/37465997 http://dx.doi.org/10.1161/STROKEAHA.123.043005

Ejemplares similares

Adiponectin Ameliorates GMH-Induced Brain Injury by Regulating Microglia M1/M2 Polarization Via AdipoR1/APPL1/AMPK/PPARγ Signaling Pathway in Neonatal Rats
por: Xu, Ningbo, et al.
Publicado: (2022)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)

Biliverdin reductase-A attenuated GMH-induced inflammatory response in the spleen by inhibiting toll-like receptor-4 through eNOS/NO pathway
por: Zhang, Yiting, et al.
Publicado: (2018)

Fractalkine/CX3CR1 signaling during neuropathic pain
por: Clark, Anna K., et al.
Publicado: (2014)

Fractalkine/CX(3)CR(1) Pathway in Neuropathic Pain: An Update
por: Silva, Rita, et al.
Publicado: (2021)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
por: Celesti, G, et al.
Publicado: (2013)

Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure
por: Woźny, Łukasz, et al.
Publicado: (2021)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
por: Imai, Toshio, et al.
Publicado: (2016)

Fractalkine Signalling (CX(3)CL1/CX(3)CR1 Axis) as an Emerging Target in Coronary Artery Disease
por: Loh, Shu Xian, et al.
Publicado: (2023)

Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina
por: Roche, Sarah L., et al.
Publicado: (2017)

Neuronal autophagy aggravates microglial inflammatory injury by downregulating CX3CL1/fractalkine after ischemic stroke
por: He, Hong-Yun, et al.
Publicado: (2019)

Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
por: Zhu, Wenjun, et al.
Publicado: (2013)

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
por: Szukiewicz, Dariusz, et al.
Publicado: (2013)

Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation
por: Oh, In-Soo, et al.
Publicado: (2015)

Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
por: Camacho-Hernández, N. P., et al.
Publicado: (2023)

Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)

Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension
por: Marasini, Bianca, et al.
Publicado: (2005)

Fractalkine receptor (CX(3)CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide
por: Corona, Angela W, et al.
Publicado: (2010)

CX3CL1 (Fractalkine) Protein Expression in Normal and Degenerating Mouse Retina: In Vivo Studies
por: Zieger, Marina, et al.
Publicado: (2014)

Neuron–glia crosstalk in health and disease: fractalkine and CX(3)CR1 take centre stage
por: Sheridan, Graham K., et al.
Publicado: (2013)

Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma
por: Upton, Nadine, et al.
Publicado: (2017)

Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats
por: Liu, Zhiming, et al.
Publicado: (2018)

Fractalkine/CX(3)CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?
por: Jeyalan, Visvesh, et al.
Publicado: (2023)

Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

CX(3)CL1 (fractalkine) and CX(3)CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
por: Sunnemark, Dan, et al.
Publicado: (2005)

CX(3)CL1 (fractalkine) and its receptor CX(3)CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin
por: Staumont-Sallé, Delphine, et al.
Publicado: (2014)

Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy
por: Jiang, Mengmeng, et al.
Publicado: (2022)

Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions
por: Jones, Brian, et al.
Publicado: (2012)

Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1
por: Stolla, Moritz, et al.
Publicado: (2012)

CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver
por: Bourd-Boittin, Katia, et al.
Publicado: (2009)

Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients
por: Cimato, Thomas R, et al.
Publicado: (2014)

Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα
por: Rutti, Sabine, et al.
Publicado: (2014)

Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation
por: Lauro, Clotilde, et al.
Publicado: (2015)

Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling
por: Roche, Sarah L., et al.
Publicado: (2016)

CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway
por: Liu, Peng, et al.
Publicado: (2018)

Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice
por: Kawamura, Namiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ki462tb5fe0mgmim47voqu01h4